Cargando…

Collateral Damage: Insulin-Dependent Diabetes Induced With Checkpoint Inhibitors

Insulin-dependent diabetes may occur in patients with cancers who are treated with checkpoint inhibitors (CPIs). We reviewed cases occurring over a 6-year period at two academic institutions and identified 27 patients in whom this developed, or an incidence of 0.9%. The patients had a variety of sol...

Descripción completa

Detalles Bibliográficos
Autores principales:	Stamatouli, Angeliki M., Quandt, Zoe, Perdigoto, Ana Luisa, Clark, Pamela L., Kluger, Harriet, Weiss, Sarah A., Gettinger, Scott, Sznol, Mario, Young, Arabella, Rushakoff, Robert, Lee, James, Bluestone, Jeffrey A., Anderson, Mark, Herold, Kevan C.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2018
Materias:	Diabetes Symposium: Emerging Areas of Islet Biology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6054443/ https://www.ncbi.nlm.nih.gov/pubmed/29937434 http://dx.doi.org/10.2337/dbi18-0002

Ejemplares similares

Islet Long Noncoding RNAs: A Playbook for Discovery and Characterization
por: Singer, Ruth A., et al.
Publicado: (2018)

Immune cells and their inflammatory mediators modify β cells and cause checkpoint inhibitor–induced diabetes
por: Perdigoto, Ana Luisa, et al.
Publicado: (2022)

Immune Checkpoint Inhibitor-Induced Hypophysitis and Patterns of Loss of Pituitary Function
por: Jessel, Shlomit, et al.
Publicado: (2022)

Precipitation of Autoimmune Diabetes With Anti-PD-1 Immunotherapy
por: Hughes, Jing, et al.
Publicado: (2015)

Spectrum of Clinical Presentations, Imaging Findings, and HLA Types in Immune Checkpoint Inhibitor–Induced Hypophysitis
por: Quandt, Zoe, et al.
Publicado: (2023)

Distinct immunologic changes in vivo following combination versus individual PD-1 or CTLA-4 checkpoint blockade in human cancer
por: Dhodapkar, Kavita, et al.
Publicado: (2014)

Inducing and Administering Tregs to Treat Human Disease
por: Perdigoto, Ana Luisa, et al.
Publicado: (2016)

Response to "NLRC5 germline variants and their potential role in eliciting an immune response in patients with cancer treated with immune checkpoint inhibitors" by Xiang-Yu Meng
por: Aizenbud, Lilach, et al.
Publicado: (2023)

Increased Reporting of Immune Checkpoint Inhibitor–Associated Diabetes
por: Wright, Jordan J., et al.
Publicado: (2018)

Germline genetic variants are associated with development of insulin-dependent diabetes in cancer patients treated with immune checkpoint inhibitors
por: Caulfield, Jasmine I, et al.
Publicado: (2023)

SAT-667 Partial Beta-Cell Destruction: An Atypical Case of Immune Checkpoint Inhibitor Diabetes Mellitus
por: Quandt, Zoe, et al.
Publicado: (2020)

Hyaluronan and Hyaluronan-Binding Proteins Accumulate in Both Human Type 1 Diabetic Islets and Lymphoid Tissues and Associate With Inflammatory Cells in Insulitis
por: Bogdani, Marika, et al.
Publicado: (2014)

How Does Type 1 Diabetes Develop?: The Notion of Homicide or β-Cell Suicide Revisited
por: Atkinson, Mark A., et al.
Publicado: (2011)

Defining Heterogeneity Among Women With Gestational Diabetes Mellitus
por: Powe, Camille E., et al.
Publicado: (2020)

Precision Medicine in Type 2 Diabetes: Using Individualized Prediction Models to Optimize Selection of Treatment
por: Dennis, John M.
Publicado: (2020)

A Primary Role for α-Cells as Amino Acid Sensors
por: Dean, E. Danielle
Publicado: (2020)

The Local Paracrine Actions of the Pancreatic α-Cell
por: Rodriguez-Diaz, Rayner, et al.
Publicado: (2020)

Repositioning Glucagon Action in the Physiology and Pharmacology of Diabetes
por: Finan, Brian, et al.
Publicado: (2020)

Single-Cell Mapping of GLP-1 and GIP Receptor Expression in the Dorsal Vagal Complex
por: Ludwig, Mette Q., et al.
Publicado: (2021)

GIPR Function in the Central Nervous System: Implications and Novel Perspectives for GIP-Basedz Therapies in Treating Metabolic Disorders
por: Samms, Ricardo J., et al.
Publicado: (2021)

The Role of GIP in the Regulation of GLP-1 Satiety and Nausea
por: Hayes, Matthew R., et al.
Publicado: (2021)

The Role of GIP Receptor in the CNS for the Pathogenesis of Obesity
por: Fukuda, Makoto
Publicado: (2021)

The Liver–α-Cell Axis in Health and in Disease
por: Richter, Michael M., et al.
Publicado: (2022)

β-Cell Mass and Type 1 Diabetes: Going, Going, Gone?
por: Akirav, Eitan, et al.
Publicado: (2008)

Survival after checkpoint inhibitors for metastatic acral, mucosal and uveal melanoma
por: Klemen, Nicholas D., et al.
Publicado: (2020)

Decreased Fetal Size Is Associated With β-Cell Hyperfunction in Early Life and Failure With Age
por: Chakravarthy, Manu V., et al.
Publicado: (2008)

miR-375 Targets 3′-Phosphoinositide–Dependent Protein Kinase-1 and Regulates Glucose-Induced Biological Responses in Pancreatic β-Cells
por: El Ouaamari, Abdelfattah, et al.
Publicado: (2008)

Postnatal Expansion of the Pancreatic β-Cell Mass Is Dependent on Survivin
por: Jiang, Yuying, et al.
Publicado: (2008)

Alterations in MicroRNA Expression Contribute to Fatty Acid–Induced Pancreatic β-Cell Dysfunction
por: Lovis, Pascal, et al.
Publicado: (2008)

Spontaneous Diabetes in Hemizygous Human Amylin Transgenic Mice That Developed Neither Islet Amyloid nor Peripheral Insulin Resistance
por: Wong, Winifred P.S., et al.
Publicado: (2008)

Hepatocyte Growth Factor Enhances Engraftment and Function of Nonhuman Primate Islets
por: Fiaschi-Taesch, Nathalie M., et al.
Publicado: (2008)

Mouse Pancreatic Endocrine Cell Transcriptome Defined in the Embryonic Ngn3-Null Mouse
por: Juhl, Kirstine, et al.
Publicado: (2008)

Cytokine-Induced β-Cell Death Is Independent of Endoplasmic Reticulum Stress Signaling
por: Åkerfeldt, Mia C., et al.
Publicado: (2008)

Small Interfering RNA–Mediated Suppression of Proislet Amyloid Polypeptide Expression Inhibits Islet Amyloid Formation and Enhances Survival of Human Islets in Culture
por: Marzban, Lucy, et al.
Publicado: (2008)

Lessons From the First Comprehensive Molecular Characterization of Cell Cycle Control in Rodent Insulinoma Cell Lines
por: Cozar-Castellano, Irene, et al.
Publicado: (2008)

β-Cell Proliferation, but Not Neogenesis, Following 60% Partial Pancreatectomy Is Impaired in the Absence of FoxM1
por: Ackermann Misfeldt, Amanda, et al.
Publicado: (2008)

MAPK Kinase Kinase-1 Is Essential for Cytokine-Induced c-Jun NH(2)-Terminal Kinase and Nuclear Factor-κB Activation in Human Pancreatic Islet Cells
por: Mokhtari, Dariush, et al.
Publicado: (2008)

Fructose-1,6-Bisphosphatase Overexpression in Pancreatic β-Cells Results in Reduced Insulin Secretion : A New Mechanism for Fat-Induced Impairment of β-Cell Function
por: Kebede, Melkam, et al.
Publicado: (2008)

PANIC-ATTAC: A Mouse Model for Inducible and Reversible β-Cell Ablation
por: Wang, Zhao V., et al.
Publicado: (2008)

Exendin-4 Stimulation of Cyclin A2 in β-Cell Proliferation
por: Song, Woo-Jin, et al.
Publicado: (2008)

Cannot write session to /tmp/vufind_sessions/sess_sjrcraf2eqd9gqc9f9m90inue6